Gain Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Good afternoon, everyone. My name is Jason Bouvier, and I'm joined by Matthias Alder, CEO of Gain Therapeutics and also Director. So welcome. I guess we'll just we'll go ahead and get started.
Thanks, Jason.
Yup. So, I thought we could just open maybe with a brief high-level overview of the company.
Thanks. So, Gain Therapeutics is actually at its core a computational drug discovery company. And the platform that we have allows us to discover novel, differentiated, first-in-class, small molecule therapies across the entire spectrum of therapeutic areas.
A very broad application of the platform have used the platform to generate the entirety of our product pipeline. And the lead program is just about the transition to clinical stage at this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
